TCMBANKIN000061 |
gaillardin |
NSC220533; Gaillardin; PLENIRADIN ACETATE; [(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-5,8-dimethyl-1-methylidene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl] ethanoate; NSC-220533; (8-hydroxy-5,8-dimethyl-1-methylidene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl) acetate; [(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-5,8-dimethyl-1-methylidene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl] acetate; 25873-32-9; 5-HYDROXY-5,8-DIMETHYL-3-METHYLIDENE-2-OXO-3AH,4H,4AH,6H,7H,7AH,9AH-AZULENO[6,5-B]FURAN-7-YL ACETATE; acetic acid [(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-5,8-dimethyl-1-methylene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl] ester; acetic acid [(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-2-keto-5,8-dimethyl-1-methylene-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[5,6-d]furan-6-yl] ester; C09455; NSC106394; 14682-46-3; [(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-5,8-dimethyl-1-methylene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl] acetate; DTXSID90309978; AC1L7KNV |
C17H22O5 |
306.4 g/mol |
CC1=CC2C(CC3C1C(CC3(C)O)OC(=O)C)C(=C)C(=O)O2 |
TCMBANKIN003503 |
utendin |
|
C21H34O5 |
366.5 g/mol |
CC(C1(CCC2(C1(C(CC3C2CC=C4C3(CCC(C4)O)C)O)C)O)O)O |
TCMBANKIN004101 |
deacylmetaplexigenin |
|
C21H32O6 |
380.5 g/mol |
CC(=O)C1(CCC2(C1(C(CC3C2(CC=C4C3(CCC(C4)O)C)O)O)C)O)O |
TCMBANKIN006854 |
lineolone |
1-[(3S,12R,13S,14R)-3,8,12,14-tetrahydroxy-10,13-dimethyl-2,3,4,7,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone; AC1NSXLA |
C21H32O5 |
364.5 g/mol |
CC(=O)C1CCC2(C1(C(CC3C2(CC=C4C3(CCC(C4)O)C)O)O)C)O |
TCMBANKIN009826 |
sarcostin |
18607-76-6; C17770; (3S,9R,10R,12R,13S,14R,17R)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta(a)phenanthrene-3,8,12,14,17-pentol; CHEBI:81323; Pregn-5-ene-3,8,12,14,17,20-hexol, (3beta,12beta,14beta,17alpha,20S)-; Sarcostin |
C21H34O6 |
382.49 |
CC(C1(CCC2(C1(C(CC3C2(CC=C4C3(CCC(C4)O)C)O)O)C)O)O)O |
TCMBANKIN011259 |
deaminoacyltaxine a |
|
C24H34O8 |
450.5 g/mol |
CC1=C2C(C(=O)C3(CC(=CC(C(C2(C)C)CC1OC(=O)C)OC(=O)C)C(CC3O)O)C)O |
TCMBANKIN016247 |
metaplexigenin |
|
C23H34O7 |
422.5 g/mol |
CC(=O)C1(CCC2(C1(C(CC3C2(CC=C4C3(CCC(C4)O)C)O)OC(=O)C)C)O)O |
TCMBANKIN019726 |
isoreineckiagenin |
|
C27H44O5 |
448.6 g/mol |
CC1C2C(CC3C2(CCC4C3CCC5C4(C(CC(C5)O)O)C)C)OC16CCC(CO6)(C)O |
TCMBANKIN020947 |
benzoylramanone |
|
C28H36O5 |
452.6 g/mol |
CC(=O)C1CCC2(C1(C(CC3C2CC=C4C3(CCC(C4)O)C)OC(=O)C5=CC=CC=C5)C)O |
TCMBANKIN023586 |
Meteloidine |
meteloidine |
C13H21NO4 |
255.31 |
CC=C(C)C(=O)OC1CC2C(C(C(C1)N2C)O)O |
TCMBANKIN030630 |
pergularin |
|
C21H32O5 |
364.5 g/mol |
CC(=O)C1(CCC2(C1(C(CC3C2CC=C4C3(CCC(C4)O)C)O)C)O)O |
TCMBANKIN034966 |
2,6-Di-O-methyl-d-galactopyranose |
|
C8H16O6 |
208.21 g/mol |
COCC1C(C(C(C(O1)O)OC)O)O |
TCMBANKIN038517 |
dibenzoylgagaimol |
|
C35H42O9 |
|
CC(C1(CCC2(C1(C(CC3C2(C(C=C4C3(CCC(C4)O)C)O)O)OC(=O)C5=CC=CC=C5)C)O)O)OC(=O)C6=CC=CC=C6 |
TCMBANKIN041788 |
pericalline |
|
C18H20N2 |
264.4 g/mol |
CC=C1CN2CCC1C(=C)C3=C(C2)C=C4C=CNC4=C3 |
TCMBANKIN041809 |
Sarcovaging A |
AC1NT083; sarcovaging a; (E)-N-[(2S,3S,4R)-17-[1-(dimethylamino)ethyl]-2,4-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-2-methylbut-2-enamide |
C28H48N2O3 |
460.78 |
[C@@]1([H])(O[H])C([H])([H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@@]([H])(N(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C2([H])[H])[C@]2
3[H])[C@@]3([H])C([H])([H])C4([H])[H])[C@]4([H])[C@@]([H])(O[H])[C@@]1([H])N([H])C(=O)\C(=C([H])\C([H])([H])[H])\C([H])([H])[H] |
TCMBANKIN043404 |
Gagaminine |
|
|
617.7 g/mol |
|
TCMBANKIN058945 |
Isoramanone |
ramanone isoramanone |
C21H32O4 |
348.48 |
CC(=O)C1CCC2(C1(C(CC3C2CC=C4C3(CCC(C4)O)C)O)C)O |
TCMBANKIN059417 |
pericalline |
|
C18H20N2 |
264.4 g/mol |
CC=C1CN2CCC1C(=C)C3=C(C2)C=C4C=CNC4=C3 |
TCMBANKIN060548 |
NSC 159627 |
|
C30H50O2 |
442.72 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)CO |